SCHEMBL13784142

SCHEMBL13784142

CCC(C)n1c(-c2ccc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc2)nc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.50
ALDH1A1 P00352 7/20 0.50
HPGD P15428 5/20 0.50
GAA P10253 4/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
GLA P06280 1/20 0.50
LMNA P02545 5/20 0.49
HSD17B10 Q99714 4/20 0.49
MAPT P10636 2/20 0.49
TP53 P04637 2/20 0.49
ALPG P10696 1/20 0.49
RAB9A P51151 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
PDE6D O43924 2/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
ALDH2 P05091 1/20 0.42
ALDH3A1 P30838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13784141 0.87 KDM4E (0.64) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13784137 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDGAALMNA
SCHEMBL13784140 0.78 HSD17B10 (0.58) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13784138 0.76 ALDH1A1 (0.65) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13784132 0.76 KDM4E (0.66) KDM4EALDH1A1HPGDGAALMNA
SCHEMBL2607467 0.76 ALDH1A1 (0.72) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13043028 0.75 PTGER4 (0.42) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13784139 0.74 TP53 (0.62) KDM4EALDH1A1HPGDGAALMNA
SCHEMBL18250747 0.74 ALDH1A1 (0.58) KDM4EALDH1A1HPGDGAAL3MBTL1
SCHEMBL13662515 0.74 ALDH1A1 (0.52) KDM4EALDH1A1HPGDGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815412-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-08-26 US disclosed
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative H1-0, NQO2, GDI1 KDM4E 443/4885ALDH1A1 499/4885HPGD 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.